Class II
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.
CGMP Deviations
- Recall number
- D-0816-2026
- Report date
- September 9, 2026
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Baxter Healthcare Corporation
- Generic names
- CLINDAMYCIN PHOSPHATE
- Brand names
- CLINDAMYCIN PHOSPHATE
- Product NDCs
- 0338-9545, 0338-9549, 0338-9553
Code and lot information
Lot # NC193689, Exp Date: 10/16/2027.
Distribution
US Nationwide; Puerto Rico; and Chile.
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on September 23, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.